Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2023.
Financials
Financial year 2025
Mdeon from Machelen (Brab.), company number BE0882170755, closed financial year 2025 with a result of € 260,551 after tax. For that financial year Mdeon recorded a gross margin of € 392,209 and equity of € 2.1 million. Compared with financial year 2024, the result moved from € 241,116 to € 260,551. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 19, 2026.
€ 2.1 million
▲ 14% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 260,551
▲ 8% vs 2024
Profit after tax over the fiscal year.
€ 934,511
▼ 4% vs 2024
Cash and bank balances on the last day of the fiscal year.
People and assets in 2025
0.7
▼ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 63,687
▲ 46% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 11,618
▲ 28% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,649
▼ 67% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 548
▼ 83% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 665,463 | € 313,207 | € 340,104 | € 392,209 | ▲ 15% |
| Profit after taxes | € 612,262 | € 243,450 | € 241,116 | € 260,551 | ▲ 8% |
| Equity | € 1,373,156 | € 1,616,606 | € 1,857,721 | € 2,118,273 | ▲ 14% |
| Total debts | € 31,474 | € 12,950 | € 8,136 | € 2,466 | ▼ 70% |
| Cash | € 1,356,083 | € 1,569,854 | € 971,048 | € 934,511 | ▼ 4% |
| Retained profit | € 1,373,156 | € 1,616,606 | € 1,857,721 | € 2,118,273 | ▲ 14% |
| Balance sheet total | € 1,404,630 | € 1,629,556 | € 1,865,857 | € 2,120,739 | ▲ 14% |
| Employees (FTE) | - | 0.5 | 0.8 | 0.7 | ▼ 0.1 |
Key figures of Mdeon, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Mdeon?
What happened at Mdeon in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- VBT - Vlaamse Beroepsvereniging Tandartsen stepped down as director. NBB
- IPSA - Instituut voor Permanente Studie voor Apothekers stepped down as director. NBB
- OPHACO - Vereniging der Cooperatieve Apotheken van België stepped down as director. NBB
- A.P.B. - Algemene Pharmaceutische Bond stepped down as director. NBB
- Medaxes - Belgische Federatie van producenten van Generische Geneesmiddelen 2 stepped down as director. NBB
- beMedTech stepped down as director. NBB
- B.V.A.S. - Belgische Vereniging van Artsensyndicaten stepped down as director. NBB
- BACHI - Belgian Association of Consumer Healthcare Industry stepped down as director. NBB
In short
From € 612,262 profit in 2022 to € 260,551 profit in 2025.
Paid € 6,001 in corporate taxes since 2022.
Best year ever: 2022, with € 612,262 profit.
A new publication or filing at Mdeon? We notify you, reason included.
Follow MdeonDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
VBT - Vlaamse Beroepsvereniging Tandartsen
Director · represented by Philippe Versluysen
since 2024 · until 2027
IPSA - Instituut voor Permanente Studie voor Apothekers
Director · represented by Maurice Malfait
since 2024 · until 2027
OPHACO - Vereniging der Cooperatieve Apotheken van België
Director · represented by Paul Perdieus
since 2024 · until 2027
A.P.B. - Algemene Pharmaceutische Bond
Director · represented by Nicolas Echement
Also active at: FEDERATION REGIONALE DES ASSOCIATIONS DE TELEMATIQUE MEDICALE
since 2024 · until 2027
Medaxes - Belgische Federatie van producenten van Generische Geneesmiddelen 2
Director · represented by Katrien Hermans
since 2024 · until 2027
Director · represented by Koen Bruylant
since 2024 · until 2027
B.V.A.S. - Belgische Vereniging van Artsensyndicaten
Director · represented by Marc Leon
since 2024 · until 2027
BACHI - Belgian Association of Consumer Healthcare Industry
Chairman of the board, Vice-chairman of the board · represented by Marc Gryseels
since 2024 · until 2027
UPV - Union Professionnelle des Vétérinaires
Director · represented by Benoit Roelants
since 2024 · until 2027
V.V.Z - Vlaamse Vereniging van Ziekenhuisinstrumentatietechnici
Director · represented by Gunther Groenen
since 2024 · until 2027
BSGP - Belgian Society of General Practioners-Family Physicians Vzw
Director · represented by Sonya Goudjil
since 2024 · until 2027
Director · represented by Vera De Troyer
Also active at: Vlaams Instituut Gezond Leven, Palliatieve Zorg Regio Dender, Kwaliteitscentrum voor Diagnostiek, In4Care Services, In4Care
since 2024 · until 2027
ASPF - Association Scientifique des Pharmaciens Francophones
Director · represented by Marie-Françoise Barbay
Also active at: SOCIETE SCIENTIFIQUE DES PHARMACIENS FRANCOPHONES
since 2024 · until 2027
V.B.S - Verbond der Belgische Beroepsverenigingen van Artsen Specialisten
Chairman of the board, Vice-chairman of the board · represented by Marianne Michel
since 2024 · until 2027
A.V.G.I. - Algemene Vereniging van de Geneesmiddelenindustrie
Director · represented by Olivia Geldof
Also active at: Patient Expert Center
since 2024 · until 2027
AUVB - Algemene Unie van Verpleegkundigen van België
Vice-chairman of the board · represented by Sigurd Vandendriessche
since 2024 · until 2027
SVH - Syndicaat van Vlaamse Huisartsen
Director · represented by Johan Brouns
since 2024 · until 2027
ASGB-GBO-SBGS/SBMS - Konfederatie der Belgische Geneesheren of Kartel
Director · represented by Roberto Salgado Figueroa
since 2024 · until 2027
Establishments
Establishment units
Physical locations of this company
Culliganlaan 2 D box 3
1831 Machelen (Brab.)
Culliganlaan 2D box 3
1831 Machelen (Brab.)
Active since 1 February 2007
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
CLOUDFLARENET - Cloudflare, Inc., US
DNS
Cloudflare DNS
Website info
Features
Security
Network
Details
- Company number
- 0882.170.755
- VAT number
- BE 0882.170.755
- Registered office
- Culliganlaan 2 D bus 3, 1831 Machelen (Brab.)
- Names & denominations
- Mdeon
- Enterprise type
- Rechtspersoon
- Legal form
- Non-profit association
- Legal situation
- Normale toestand
- Start date
- 29 June 2006
- Peppol
- Active · Active since 30 Jan 2025
- Contact
- mdeon.be [email protected]
- Activities · NACE
Activiteiten van bedrijfs- en werkgeversorganisaties
Overige zakelijke dienstverlening, neg
Overige zakelijke dienstverlening, n.e.g.